findmyKOL
Clinical trialNCT06496581RecruitingPhase 3Interventional

Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)

SponsorUNICANCEREnrollment500Prostate Cancer Metastatic
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Institut de Cancérologie de L'Ouest

    Angers, France

    Elouen Boughalem, MD
    Not, yet, recruiting
  • Institut Bergonié

    Bordeaux, France

    Paul Schwartz, MD
    Not, yet, recruiting
  • Chru Brest

    Brest, France

    Friederike Schlurmann, MD
    Not, yet, recruiting
  • Centre Francois Baclesse

    Caen, France

    Florence Joly, MD
    Not, yet, recruiting
  • Chu Henri Mondor

    Créteil, France

    Caroline Saldana, MD
    Not, yet, recruiting
  • Centre Georges-François Leclerc

    Dijon, France

    Clément Drouet, MD
    Not, yet, recruiting
  • Chu Grenoble

    Grenoble, France

    Loic Djaileb, MD
    Not, yet, recruiting
  • Centre Léon Berard

    Lyon, France

    Aude Flechon, MD
    Not, yet, recruiting
  • Institut Paoli-Calmettes

    Marseille, France

    Gwenaelle Gravis, MD
    Recruiting
  • Chru Nancy

    Nancy, France

    Pierre Olivier, MD
    Not, yet, recruiting
  • Centre Antoine Lacassagne

    Nice, France

    Delphine Borchiellini, MD
    Not, yet, recruiting
  • Hôpital Cochin

    Paris, France

    Olivier Hullard, MD
    Not, yet, recruiting
  • Hôpital Saint Louis

    Paris, France

    Hélène Gauthier, MD
    Not, yet, recruiting
  • Institut Curie

    Paris, France

    Zahra Castel-Ajgal, MD
    Not, yet, recruiting
  • Centre Eugène Marquis

    Rennes, France

    Laurence Crouzet, MD
    Recruiting
  • Chu Rouen

    Rouen, France

    Laetitia Augusto, MD
    Not, yet, recruiting
  • Centre Henri Becquerel

    Rouen, France

    David Tonnelet, MD
    Not, yet, recruiting
  • Institut Curie

    Saint-Cloud, France

    Capucine Richard, MD
    Not, yet, recruiting
  • Institut de Cancérologie de L'Ouest

    Saint-Herblain, France

    Emmanuelle Bompas, MD
    Not, yet, recruiting
  • Chu Saint Etienne

    Saint-Priest-en-Jarez, France

    Pierre Cornillon, MD
    Not, yet, recruiting
  • Icans

    Strasbourg, France

    Philippe Barthelemy, MD
    Not, yet, recruiting
  • Iuct Oncopole

    Toulouse, France

    Loic Mourey, MD
    Not, yet, recruiting
  • Chru Tours

    Tours, France

    Mathilde Cancel, MD
    Not, yet, recruiting
  • Institut de Cancérologie de Lorraine

    Vandœuvre-lès-Nancy, France

    Vincent MASSARD, MD
    Not, yet, recruiting
  • Gustave Roussy

    Villejuif, France

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

177Lu-PMSA-617Standard of Care
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
12 Sept 2024
Primary completion
1 Feb 2033
Completion
1 Aug 2039
Last update posted
20 Dec 2024
Registered enrollment
500
Registry id
NCT06496581

Cross-registrations

EU-CTR / CTIS (EudraCT)2022-502408-57-00

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.